Shenyang Xingqi Pharmaceutical Co Ltd Cash Flow Conversion Efficiency
Shenyang Xingqi Pharmaceutical Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Shenyang Xingqi Pharmaceutical Co Ltd (300573) has a cash flow conversion efficiency ratio of 0.145x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥268.97 Million ≈ $39.36 Million USD) by net assets (CN¥1.86 Billion ≈ $271.78 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Shenyang Xingqi Pharmaceutical Co Ltd (2011–2024)
Cash flow conversion efficiency of Shenyang Xingqi Pharmaceutical Co Ltd from 2011 to 2024. This chart illustrates how Shenyang Xingqi Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 300573 share price today for real-time trading data and today's change.
Shenyang Xingqi Pharmaceutical Co Ltd Cash Flow Conversion Ratio Explained
Shenyang Xingqi Pharmaceutical Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Shenyang Xingqi Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Shenyang Xingqi Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Also see Shenyang Xingqi Pharmaceutical Co Ltd (300573) market capitalisation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
HuBei SanFeng Intelligent Conveying Equipment Co Ltd
SHE:300276
|
0.100x |
|
Hubei Jianghan New Materials Co. Ltd. A
SHG:603281
|
N/A |
|
STAAR Surgical Company
NASDAQ:STAA
|
0.054x |
|
Edelweiss Financial Services Limited
NSE:EDELWEISS
|
-0.118x |
|
Nabors Industries Ltd
F:NBI1
|
0.079x |
|
Jinhui Liquor Co Ltd
SHG:603919
|
-0.011x |
|
Landis+Gyr Group AG
SW:LAND
|
0.066x |
|
Klöckner & Co SE
XETRA:KCO
|
-0.164x |
Annual Cash Flow Conversion Efficiency for Shenyang Xingqi Pharmaceutical Co Ltd (2011–2024)
The table below shows the annual cash flow conversion efficiency of Shenyang Xingqi Pharmaceutical Co Ltd from 2011 to 2024. Review cash generation quality of Shenyang Xingqi Pharmaceutical Co Ltd to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥1.59 Billion ≈ $233.13 Million |
CN¥416.98 Million ≈ $61.02 Million |
0.262x | +39.28% |
| 2023-12-31 | CN¥1.69 Billion ≈ $247.29 Million |
CN¥317.57 Million ≈ $46.47 Million |
0.188x | +1.90% |
| 2022-12-31 | CN¥1.55 Billion ≈ $227.15 Million |
CN¥286.26 Million ≈ $41.89 Million |
0.184x | -19.23% |
| 2021-12-31 | CN¥1.34 Billion ≈ $196.74 Million |
CN¥306.96 Million ≈ $44.92 Million |
0.228x | +29.72% |
| 2020-12-31 | CN¥694.06 Million ≈ $101.56 Million |
CN¥122.16 Million ≈ $17.88 Million |
0.176x | +36.59% |
| 2019-12-31 | CN¥574.90 Million ≈ $84.13 Million |
CN¥74.08 Million ≈ $10.84 Million |
0.129x | +62.38% |
| 2018-12-31 | CN¥554.58 Million ≈ $81.15 Million |
CN¥44.01 Million ≈ $6.44 Million |
0.079x | +34.31% |
| 2017-12-31 | CN¥553.38 Million ≈ $80.98 Million |
CN¥32.70 Million ≈ $4.78 Million |
0.059x | +9.45% |
| 2016-12-31 | CN¥520.95 Million ≈ $76.23 Million |
CN¥28.12 Million ≈ $4.12 Million |
0.054x | -1.82% |
| 2015-12-31 | CN¥389.79 Million ≈ $57.04 Million |
CN¥21.43 Million ≈ $3.14 Million |
0.055x | +55.59% |
| 2014-12-31 | CN¥367.81 Million ≈ $53.82 Million |
CN¥13.00 Million ≈ $1.90 Million |
0.035x | +41.72% |
| 2013-12-31 | CN¥336.80 Million ≈ $49.28 Million |
CN¥8.40 Million ≈ $1.23 Million |
0.025x | -82.72% |
| 2012-12-31 | CN¥290.70 Million ≈ $42.54 Million |
CN¥41.96 Million ≈ $6.14 Million |
0.144x | +45.29% |
| 2011-12-31 | CN¥247.00 Million ≈ $36.14 Million |
CN¥24.54 Million ≈ $3.59 Million |
0.099x | -- |
About Shenyang Xingqi Pharmaceutical Co Ltd
Shenyang Xingqi Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of ophthalmic medications in the People's Republic of China. The company provides myopia prevention and control medications, nutrition and corneal repair drugs, ophthalmic anti-inflammatory/anti-infective drugs, artificial tears and eye lubricants, ophthalmic non-steroidal anti-inflammatory drugs… Read more